Edition:
United Kingdom

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

1.60USD
21 May 2019
Change (% chg)

$-0.22 (-12.09%)
Prev Close
$1.82
Open
$1.60
Day's High
$1.69
Day's Low
$1.50
Volume
158,897
Avg. Vol
64,144
52-wk High
$5.10
52-wk Low
$1.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.12 December 22 May 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 3 5.60 6.30 5.20 13.54
Quarter Ending Sep-19 3 6.14 6.75 5.80 9.26
Year Ending Dec-19 3 23.03 25.06 21.20 41.19
Year Ending Dec-20 2 35.27 43.83 26.70 60.02
Earnings (per share)
Quarter Ending Jun-19 3 -0.12 -0.11 -0.13 0.09
Quarter Ending Sep-19 3 -0.10 -0.07 -0.13 -0.06
Year Ending Dec-19 3 -0.50 -0.41 -0.57 -0.20
Year Ending Dec-20 2 -0.29 -0.28 -0.30 0.12

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 5.79 4.91 0.89 15.29
Quarter Ending Dec-18 5.47 4.15 1.31 24.00
Quarter Ending Sep-18 5.23 3.83 1.39 26.65
Quarter Ending Jun-18 3.98 3.92 0.06 1.57
Quarter Ending Mar-18 3.58 3.18 0.40 11.08

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 5.60 5.60 6.12 6.12 13.54
Quarter Ending Sep-19 6.14 6.14 6.80 6.80 9.26
Year Ending Dec-19 23.03 23.44 25.56 25.56 41.19
Year Ending Dec-20 35.27 35.27 36.83 36.83 60.02

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-19 1 0 1 2
Quarter Ending Sep-19 1 0 1 2
Year Ending Dec-19 0 1 0 3
Year Ending Dec-20 0 0 1 1
Earnings